Detection of C-MYC oncogene translocation and copy number change in the normal-dysplasia-carcinoma sequence of the larynx by fluorescence in situ hybridization

Diagnostic Cytopathology

Volumn 41, Issue 6, 2013, Pages 515-519

  Liu, Yu ^a   Gong, Li Ping ^b   Dong, Xiao Li ^b   Liu, Hong Gang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

C MYC; copy number change; dysplasia; fluorescent in situ hybridization; laryngeal carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CARCINOMA IN SITU; COPY NUMBER VARIATION; DIAGNOSTIC EQUIPMENT; DISEASE SEVERITY; DYSPLASIA; EARLY DIAGNOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENE AMPLIFICATION; GENE TRANSLOCATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LARYNGEAL DYSPLASIA; LARYNX MUCOSA; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; PRECANCER; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; FEMALE; GENE DOSAGE; GENES, MYC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; TRANSLOCATION, GENETIC;

EID: 84878018992     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.22879     Document Type: Article

References (34)

1. Liang H, Wang J, Xiao H, et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health 2010; 10: 730. doi:10.1186/1471-2458-10-730.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005; 55: 10-30.
3. Licitra L, Bernier J, Grandi C, et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003; 47: 65-80.
4. Mao L, Hong WK, Papadimitrakopoulou VA,. Focus on head and neck cancer. Cancer Cell 2004; 5: 311-316.
5. Keser I, Toraman AD, Ozbilim G, Guney K, Luleci G,. DNA gains and losses of chromosome in laryngeal squamous cell carcinoma using comparative genomic hybridization. Yonsei Med J 2008; 49: 949-954.
6. Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002; 161: 1051-1060.
7. Zukerberg L,. The molecular basis of dysplasia. Semin Diagn Pathol 2002; 19: 48-53.
8. Johnson FL,. Management of advanced premalignant laryngeal lesions. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 462-466.
9. Ventura RA, Martin-Subero JI, Jones M, et al. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 2006; 8: 141-151.
10. Haralambieva E, Kleiverda K, Mason DY, Schuuring E, Kluin PM,. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol 2002; 198: 163-170.
11. Ha PK, Califano JA, 3rd,. The molecular biology of laryngeal cancer. Otolaryngol Clin North Am 2002; 35: 993-1012.
12. Gale N, Michaels L, Luzar B, et al. Current review on squamous intraepithelial lesions of the larynx. Histopathology 2009; 54: 639-656.
13. Parrella P, Caballero OL, Sidransky D, Merbs SL,. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization. Invest Ophthalmol Vis Sci 2001; 42: 1679-1684.
14. Mai S, Mushinski JF,. c-Myc-induced genomic instability. J Environ Pathol Toxicol Oncol 2003; 22: 179-199.
15. Nesbit CE, Tersak JM, Prochownik EV,. MYC oncogenes and human neoplastic disease. Oncogene 1999; 18: 3004-3016.
16. Boxer LM, Dang CV,. Translocations involving c-myc and c-myc function. Oncogene 2001; 20: 5595-5610.
17. Romeo MS, Sokolova IA, Morrison LE, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn 2003; 5: 103-112.
18. Yoon SO, Jeon YK, Paik JH, et al. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology 2008; 53: 205-217.
19. Veltman JA, Bot FJ, Huynen FC, Ramaekers FC, Manni JJ, Hopman AH,. Chromosome instability as an indicator of malignant progression in laryngeal mucosa. J Clin Oncol 2000; 18: 1644-1651.
20. Nadal A, Cardesa A,. Molecular biology of laryngeal squamous cell carcinoma. Virchows Arch 2003; 442: 1-7.
21. Saglam O, Shah V, Worsham MJ,. Molecular differentiation of early and late stage laryngeal squamous cell carcinoma: an exploratory analysis. Diagn Mol Pathol 2007; 16: 218-221.
22. Huang Q, Yu GP, McCormick SA, et al. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 2002; 34: 224-233.
23. Hermsen M, Alonso Guervos M, Meijer G, et al. Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma. Cell Oncol 2005; 27: 191-198.
24. Hermsen M, Guervos MA, Meijer G, et al. New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol 2001; 194: 177-182.
25. Squire JA, Bayani J, Luk C, et al. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 2002; 24: 874-887.
26. Juhasz A, Balazs M, Sziklay I, et al. Chromosomal imbalances in laryngeal and hypopharyngeal cancers detected by comparative genomic hybridization. Cytometry A 2005; 67: 151-160.
27. Patmore HS, Ashman JN, Stafford ND, et al. Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett 2007; 258: 55-62.
28. Taubald A, Liehr T, Ries J, Girod S, Hassfurter E, Gebhart E,. CGH-detected DNA sequence copy number amplifications can be confirmed by interphase-FISH: new possiblities for prognostic approaches in oral squamous cell carcinomas. Int J Mol Med 1998; 2: 555-560.
29. Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK,. Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer 1991; 48: 511-515.
30. Rodrigo JP, Lazo PS, Ramos S, Alvarez I, Suarez C,. MYC amplification in squamous cell carcinomas of the head and neck. Arch Otolaryngol Head Neck Surg 1996; 122: 504-507.
31. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003; 63: 1179-1182.
32. Koynova DK, Tsenova VS, Toncheva DI,. Tissue microarray analysis of C-MYC oncogene copy number changes in larynx carcinoma. ORL J Otorhinolaryngol Relat Spec 2005; 67: 92-95.
33. Bhattacharya N, Roy A, Roy B, Roychoudhury S, Panda CK,. MYC gene amplification reveals clinical association with head and neck squamous cell carcinoma in Indian patients. J Oral Pathol Med 2009; 38: 759-763.
34. Shah NG, Trivedi TI, Tankshali RA, et al. Molecular alterations in oral carcinogenesis: significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers 2007; 22: 132-143.